Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Improving paediatric epilepsy management at the first level of care: a pilot education intervention for clinical officers in Zambia.
BMJ Open. 2019 Jul 24;9(7):e029322. doi: 10.1136/bmjopen-2019-029322.
BMJ Open. 2019.
PMID: 31345977
Free PMC article.
A retrospective observational study of EEG findings and antiepileptic drug use among children referred for EEG to Zambia's University Teaching Hospital.
Ciccone O, Chabala C, Tembo O, Mathew M, Grollnek AK, Patel AA, Birbeck GL.
Ciccone O, et al. Among authors: tembo o.
Epilepsia Open. 2018 Oct 16;3(4):503-510. doi: 10.1002/epi4.12267. eCollection 2018 Dec.
Epilepsia Open. 2018.
PMID: 30525119
Free PMC article.
Item in Clipboard
Long-term outcome of the REMAGUS 02 trial, a multicenter randomised phase II trial in locally advanced breast cancer patients treated with neoadjuvant chemotherapy with or without celecoxib or trastuzumab according to HER2 status.
Giacchetti S, Hamy AS, Delaloge S, Brain E, Berger F, Sigal-Zafrani B, Mathieu MC, Bertheau P, Guinebretière JM, Saghatchian M, Lerebours F, Mazouni C, Tembo O, Espié M, Reyal F, Marty M, Asselain B, Pierga JY.
Giacchetti S, et al. Among authors: tembo o.
Eur J Cancer. 2017 Apr;75:323-332. doi: 10.1016/j.ejca.2017.01.008. Epub 2017 Mar 7.
Eur J Cancer. 2017.
PMID: 28279941
Clinical Trial.
Item in Clipboard
BIRC5 (survivin): a pejorative prognostic marker in stage II/III breast cancer with no response to neoadjuvant chemotherapy.
Hamy AS, Bieche I, Lehmann-Che J, Scott V, Bertheau P, Guinebretière JM, Matthieu MC, Sigal-Zafrani B, Tembo O, Marty M, Asselain B, Spyratos F, de Cremoux P.
Hamy AS, et al. Among authors: tembo o.
Breast Cancer Res Treat. 2016 Oct;159(3):499-511. doi: 10.1007/s10549-016-3961-2. Epub 2016 Sep 3.
Breast Cancer Res Treat. 2016.
PMID: 27592112
Item in Clipboard
Challenging single- and multi-probesets gene expression signatures of pathological complete response to neoadjuvant chemotherapy in breast cancer: experience of the REMAGUS 02 phase II trial.
Valet F, de Cremoux P, Spyratos F, Servant N, Dujaric ME, Gentien D, Lehmann-Che J, Scott V, Sigal-Zafrani B, Mathieu MC, Bertheau P, Guinebretière JM, Pierga JY, Delaloge S, Giacchetti S, Brain E, Tembo O, Marty M, Asselain B.
Valet F, et al. Among authors: tembo o.
Breast. 2013 Dec;22(6):1052-9. doi: 10.1016/j.breast.2013.08.015. Epub 2013 Oct 2.
Breast. 2013.
PMID: 24095610
Free article.
Clinical Trial.
Item in Clipboard
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab.
Cizkova M, Dujaric ME, Lehmann-Che J, Scott V, Tembo O, Asselain B, Pierga JY, Marty M, de Cremoux P, Spyratos F, Bieche I.
Cizkova M, et al. Among authors: tembo o.
Br J Cancer. 2013 May 14;108(9):1807-9. doi: 10.1038/bjc.2013.164. Epub 2013 Apr 23.
Br J Cancer. 2013.
PMID: 23612454
Free PMC article.
Item in Clipboard
Comments on the use of a single or multiple probeset approach for microarray-based analyses of routine molecular markers in breast cancer.
Spyratos F, Valet F, Bièche I, Scott V, Lehmann-Che J, Asselain B, Tembo O, Marty M, de Cremoux P.
Spyratos F, et al. Among authors: tembo o.
Breast Cancer Res Treat. 2012 Jul;134(1):443-8. doi: 10.1007/s10549-012-2042-4. Epub 2012 Apr 12.
Breast Cancer Res Treat. 2012.
PMID: 22527097
No abstract available.
Item in Clipboard
Cite
Cite